Comprarison of Risendronate and Raloxifene Treatment in Postmenopausal Osteoporosis - Original Investigation
Aim: The aim of this study was to compare the efficacy of risendronate and raloxifene treatments on bone mineral density (BMD) and biochemical markers of bone turnover in postmenopausal osteoporosis. Material and Method: Eighty-tree patients were randomly assigned to two groups. Forty-two patients...
Main Authors: | Dilek Koç Yılmaz, Onur Armağan, Ayşe Ekim, Funda Taşçıoğlu, Cengiz Öner |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2006-09-01
|
Series: | Türk Osteoporoz Dergisi |
Subjects: | |
Online Access: | http://www.turkosteoporozdergisi.org/article_4151/Comprarison-Of-Risendronate-And-Raloxifene-Treatment-In-Postmenopausal-Osteoporosis-Original-Investigation |
Similar Items
-
The Comparison of Effects of Alendronate and Raloxifene Treatment in Postmenopausal Women with Osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006-03-01) -
Role of raloxifene in the management of postmenopausal osteoporosis of rheumatoid arthritis patients
by: Salari M., et al.
Published: (2023-09-01) -
Effects of Alendronate, Calcitonin and Raloxifene Used in the Treatment of Postmenopausal Osteoporosis On Serum No Levels
by: Saliha Karatay, et al.
Published: (2005-03-01) -
The Effects of Once-Weekly Alendronate 70 mg, Risedronate 35 mg and Raloxifene 60 mg Daily in the Treatment of Postmenopausal Osteoporosis in Turkish Population
by: Mesut Öktem, et al.
Published: (2007-04-01) -
Evalution the Effects of Raloxifene and Risedronate on Serum Biochemical Markers
by: Abdurrahman Yeter, et al.
Published: (2014-12-01)